PC(38:4)
|
Basic information |
| Metabolite name | PC(38:4) |
 | N/A |
 |
C00157 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 8 |
|
Relationship between PC(38:4) and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M039 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Down |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M122 | Type3 | paroxetine group vs. control group | Prefrontal cortex | BALB/c mouse | Down |
| Study M124 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
| Study M734 | Type1 | CRS group vs. control group | Liver | C57BL/6 mouse | Up |
| Study M775 | Type1 | prenatal stress group vs. control group | Brain | Swiss Webster mouse | Down |
| Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M789 | Type2 | CUMS + liquiritin group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |
| Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Up |